Dark Forest Capital Management’s Terns Pharmaceuticals TERN Stock Holding History

Dark Forest Capital Management’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$548K	Buy	10,400 +31	+0.3%	+$1.27K	0.05%	531
2025 Q4	$419K	Buy	+10,369	New	+$240K	0.02%	841
2024 Q4	–	Sell	-26,269	Closed	-$219K	–	1280
2024 Q3	$219K	Buy	+26,269	New	+$216K	0.03%	832
2023 Q2	–	Sell	-3,852	Closed	-$45.6K	–	1388
2023 Q1	$45.6K	Buy	+3,852	New	+$36.8K	0.01%	859

Other funds holding TERN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Dark Forest Capital Management's TERN Position: Q1 2026 in Review

Dark Forest Capital Management increased its Terns Pharmaceuticals (TERN) stake by 0.3% in Q1 2026, buying an estimated $1.27K and bringing the position to 10,400 shares worth $548K. The position accounts for 0.05% of the portfolio, ranked #531.

Dark Forest Capital Management first reported a position in TERN in Q1 2023 and has held it in 4 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

Dark Forest Capital Management held 10,400 shares of Terns Pharmaceuticals worth $548K as of Q1 2026.
Dark Forest Capital Management bought 31 Terns Pharmaceuticals shares in Q1 2026, an estimated $1.27K.
Terns Pharmaceuticals made up 0.05% of Dark Forest Capital Management's portfolio in Q1 2026, its #531 holding.
Dark Forest Capital Management first reported a position in Terns Pharmaceuticals in Q1 2023 and has held it in 4 quarters since.
317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Dark Forest Capital Management's 13F filing for Q1 2026, filed 15 May 2026.